Form4insider filings, from the source

SEC Form 4 · accession 0000899243-16-019823

Intellia Therapeutics, Inc. · NTLA

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Period of report
May 11, 2016
Accepted (ET)
May 13, 2016 · 6:15 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001652130

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2May 11, 2016C490,527—A490,527IHeld by TLS Beta Pte. Ltd.
Common StockF3May 11, 2016P300,000$18.00A790,527ISee footnote

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Series B Preferred StockF2,F1,F4—May 11, 2016C490,527D——Common Stock490,5270I

Explanation of responses